Stay updated on Pembrolizumab for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:41:32.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T21:14:49.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision tag on the site changed from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:13:29.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added the long-form study title for Pembrolizumab in HBV-related hepatocellular carcinoma and later removed an alternate title variant, with related regulatory notes.
    Difference
    0.6%
    Check dated 2026-03-05T17:59:45.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now active, replacing v3.4.1. This update does not appear to change the study details or other critical information.
    Difference
    0.1%
    Check dated 2026-02-12T01:45:39.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 indicates a minor platform release. No observable changes to study content or user-facing features were detected; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T22:54:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.